Correlation Between Amgen and OptiNose
Can any of the company-specific risk be diversified away by investing in both Amgen and OptiNose at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amgen and OptiNose into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amgen Inc and OptiNose, you can compare the effects of market volatilities on Amgen and OptiNose and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amgen with a short position of OptiNose. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amgen and OptiNose.
Diversification Opportunities for Amgen and OptiNose
Average diversification
The 3 months correlation between Amgen and OptiNose is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and OptiNose in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OptiNose and Amgen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amgen Inc are associated (or correlated) with OptiNose. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OptiNose has no effect on the direction of Amgen i.e., Amgen and OptiNose go up and down completely randomly.
Pair Corralation between Amgen and OptiNose
Given the investment horizon of 90 days Amgen is expected to generate 3.06 times less return on investment than OptiNose. But when comparing it to its historical volatility, Amgen Inc is 5.37 times less risky than OptiNose. It trades about 0.2 of its potential returns per unit of risk. OptiNose is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 620.00 in OptiNose on December 29, 2024 and sell it today you would earn a total of 295.00 from holding OptiNose or generate 47.58% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Amgen Inc vs. OptiNose
Performance |
Timeline |
Amgen Inc |
OptiNose |
Amgen and OptiNose Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Amgen and OptiNose
The main advantage of trading using opposite Amgen and OptiNose positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amgen position performs unexpectedly, OptiNose can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OptiNose will offset losses from the drop in OptiNose's long position.The idea behind Amgen Inc and OptiNose pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.OptiNose vs. Collegium Pharmaceutical | OptiNose vs. Phibro Animal Health | OptiNose vs. ANI Pharmaceuticals | OptiNose vs. Procaps Group SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Fundamental Analysis View fundamental data based on most recent published financial statements |